Molecular Health and Axxam Join Forces: Unlocking Innovative Drug Development Targets Together!

Axxam S.p.A. and Molecular Health GmbH are teaming up to enhance drug discovery processes. Based in Milan and Heidelberg, these two companies aim to streamline how new treatments are developed by combining Axxam’s early drug discovery methods with Molecular Health’s advanced AI technology.

This collaboration will integrate Molecular Health’s Dataome platform into Axxam’s DiscoveryMAXX process. Dataome helps gather and organize various data types—molecular, phenotypic, and clinical—making it easier for pharmaceutical companies to identify and validate potential drug targets. The goal here is to blend clinical insights with thorough biological experimentation to find effective therapies faster.

Ciriaco Maraschiello, CEO of Axxam, emphasizes the importance of identifying the right targets in drug discovery. He points out that using biology-driven methods to validate predictions can lead to better real-world therapies. This partnership aims to boost the accuracy and speed of drug discovery, allowing clients to make quicker, informed decisions during development phases.

Friedrich von Bohlen, CEO of Molecular Health, supports this idea. He notes that understanding the links between molecular variations and diseases is crucial for improving success rates in drug development. By combining their expertise, Axxam and Molecular Health can enhance drug discovery and clinical programs significantly.

This partnership arrives at a time when the pharmaceutical industry increasingly relies on AI. A 2022 report found that 70% of companies using AI in drug development reported improved efficiencies. This trend suggests that integrating AI could soon become standard practice, making it vital for companies to stay ahead.

Overall, Axxam and Molecular Health are striving to bridge the gap between data-driven predictions and biological insights, promising innovative solutions for pharmaceutical companies worldwide.

For more details about Axxam, visit Axxam.com, and for insights on Molecular Health, head to MolecularHealth.com.

Source link

Molecular Health, Molecular Health, Axxam, strategic partnership, drug development